E
Tivic Health Systems, Inc. TIVC
$2.09 -$0.58-21.62% NASDAQ
Recommendation
Prev Close
$2.09
Volume
150,604
Avg Vol (90D)
742,386
Market Cap
$3.68M
Dividend & Yield
--
52-Week Range
$1.47 - $15.64
P/E (TTM)
--
EPS (TTM)
-$9.91
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package
12/11/2025 - ACCESS Newswire
Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome
11/18/2025 - ACCESS Newswire
Tivic Health's Earnings Call: Strategic Shift and Challenges
11/16/2025 - TipRanks Financial Blog
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q3 2025 Earnings Call Transcript
11/15/2025 - Insider Monkey
Tivic Reports Third Quarter 2025 Financial Results
11/14/2025 - ACCESS Newswire
Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)
11/13/2025 - ACCESS Newswire
Tivic Expands Intellectual Property Portfolio
11/10/2025 - Business Wire
Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast
11/6/2025 - Business Wire
Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23
10/22/2025 - Business Wire
Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream
9/24/2025 - Globe Newswire
Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream
9/23/2025 - Globe Newswire
Tivic Health CEO Jennifer Ernst to Present at Emerging Growths September Virtual Conference
9/22/2025 - Business Wire
Tivic Completes Verification of Entolimod Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing
9/10/2025 - Business Wire
Tivic Receives Two Investigational New Drug Applications for Entolimod for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers
8/20/2025 - Business Wire
Promising Penny Stocks To Consider - August 17th
8/19/2025 - MarketBeat
Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025
8/15/2025 - Business Wire
Tivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call Transcript
8/14/2025 - Seeking Alpha: Transcripts
Tivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call Transcript
8/14/2025 - SeekingAlpha
Tivic Health Sales Drop 39 Percent
8/14/2025 - Fool.com Headlines
Tivic Reports Second Quarter 2025 Financial Results
8/14/2025 - Business Wire
Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast
8/7/2025 - Business Wire
Critical Comparison: Tivic Health Systems (NASDAQ:TIVC) versus Nyxoah (NASDAQ:NYXH)
8/6/2025 - Ticker Report
Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO
7/8/2025 - Business Wire
Tivic Health Systems Appoints Lisa Wolf as CFO
7/7/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$482.00K
EBITDA (TTM)
-$7.46M
EBIT (TTM)
-$7.47M
Net Income (TTM)
-$7.51M
Balance Sheet
Total Assets (Q)
$6.23M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$638.00K
Book Value Per Share (Q)
$3.36
Cash Flow
Cash from Operations (TTM)
-$6.08M
Cash from Investing (TTM)
-$556.00K
Cash from Financing (TTM)
$7.89M
Net Change in Cash (TTM)
$1.26M
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
0.96
7-Day Total Return
2.21%
30-Day Total Return
-16.93%
60-Day Total Return
-32.08%
90-Day Total Return
-33.62%
Year to Date Total Return
-64.24%
1-Year Total Return
-44.00%
2-Year Total Return
-93.03%
3-Year Total Return
-99.86%
5-Year Total Return
--
52-week Low
Nov 17, 2025 - $1.47
52-week High
Feb 13, 2025 - $15.64
Valuation
Market Cap
$3.68M - Nano Cap
Enterprise Value
$232.01K
Price/Sales (TTM)
5.71
Price/Book (Q)
0.62
Dividends and Shares
Shares Outstanding
1.32
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
tivichealth.com
Phone Number
888 276 6888
Address
47685 Lakeview Blvd.
Fremont, CA 94538
Country
United States
Year Founded
2016
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus... more
NASDAQ 12/12/2025 3:59PM Eastern Quotes delayed